secwatch.observer — SEC 8-K summary
======================================

Issuer:     GeneDx Holdings Corp. (WGS)
CIK:        0001818331
Form:       8-K
Filed at:   2022-04-27T23:59:59+00:00
Accession:  0001628280-22-010817
Event type: m_and_a
Sentiment:  positive
Materiality: 0.80
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Sema4 shareholders approve GeneDx acquisition, authorize share increase to 1B
-----------------------------------------------------------------------------

- Stockholders approved shares for GeneDx acquisition: 178,157,301 for, 104,365 against.
- Approved PIPE investment issuance: 178,106,518 for, 153,719 against.
- Approved charter amendment increasing authorized Class A common from 380M to 1B shares.
- Elected three Class I directors to serve three-year terms expiring 2025.
- Ratified Ernst & Young as independent auditor for fiscal year 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818331/000162828022010817/0001628280-22-010817-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818331/000162828022010817/smfr-20220427.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-010817

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer